LOGIN
Allograft vs. Bioactive Glass for Pediatric Benign Bone Lesions: A Randomized Trial
July 2023
Allograft vs. Bioactive Glass for Pediatric Benign Bone Lesions: A Randomized Trial
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Allograft Versus Bioactive Glass (BG-S53P4) in Pediatric Benign Bone Lesions: A Randomized Clinical Trial.
J Bone Joint Surg Am. 2023 May 3;105(9):659-666.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
51 children with benign bone cysts were randomized to receive intralesional curettage and filling with an allograft (n=26) or with bioactive glass (n=25) the primary outcome of interest was the volume of recurrent cysts at 24 months follow-up. Secondary outcomes of interest included the recurrence rate, risk of re-operation, Musculoskeletal Tumour Society (MSTS) Score, and complications. The resul...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.